Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Other financing activities (2017 - 2025)

Sensus Healthcare (SRTS) has 9 years of Other financing activities data on record, last reported at $76000.0 in Q4 2025.

  • For Q4 2025, Other financing activities fell 37.7% year-over-year to $76000.0; the TTM value through Dec 2025 reached $300000.0, down 7.69%, while the annual FY2025 figure was $300000.0, 7.69% down from the prior year.
  • Other financing activities reached $76000.0 in Q4 2025 per SRTS's latest filing, up from $73000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $206000.0 in Q3 2021 and bottomed at -$57000.0 in Q3 2022.
  • Average Other financing activities over 5 years is $79800.0, with a median of $69500.0 recorded in 2023.
  • Peak YoY movement for Other financing activities: skyrocketed 456.76% in 2021, then plummeted 127.67% in 2022.
  • A 5-year view of Other financing activities shows it stood at $90000.0 in 2021, then skyrocketed by 74.44% to $157000.0 in 2022, then plummeted by 59.24% to $64000.0 in 2023, then soared by 90.62% to $122000.0 in 2024, then plummeted by 37.7% to $76000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other financing activities were $76000.0 in Q4 2025, $73000.0 in Q3 2025, and $72000.0 in Q2 2025.